Rakuten Medical
Rakuten Medical, Inc. is a global biotechnology company headquartered in San Diego, California, developing precision, cell-targeting investigational cancer therapies on its proprietary Alluminox platform — a drug-device combination pairing an IRDye 700DX light-activated dye conjugated to a cell-targeting antibody with local illumination by 690nm red light. Founded in 2010 as Aspyrian Therapeutics and renamed following investment from Rakuten Group, the company operates in the United States, Japan, Taiwan, Switzerland and India. Its lead asset ASP-1929, an EGFR-targeting antibody-dye conjugate, received marketing approval in Japan in 2021 as Akalux for unresectable locally advanced or recurrent head and neck cancer and is in global Phase 3 development alone and in combination with anti-PD-1 therapy; RM-1995 and RM-0256 follow in earlier-stage programs. As a clinical-stage therapeutics and drug-device company, Rakuten Medical publishes no public developer API, SDK, webhook, or machine-readable specification; this profile captures its corporate identity and public web properties in the API Evangelist network.
Rakuten Medical is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Healthcare.
Rakuten Medical’s developer surface includes engineering blog, product news, support, and 9 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 7
The organization behind the API
Scroll for all 7
Other 1
Properties that don't map to a standard resource type